Paper31433998
Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission.
Laube B and 5 others. Regul Toxicol Pharmacol, 2019. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission. Papers, record 31433998. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31433998
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Air Pollutants, Occupational | Major topic |
| Carcinogens | Major topic |
| Guidelines as Topic | Major topic |
| Animals | |
| Germany | |
| Government Agencies | |
| Humans | |
| International Agencies | |
| Neoplasms | |
| Occupational Diseases | |
| Occupational Exposure | |
| Risk Assessment | |
| Species Specificity |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42657353 | 2,2'-Dichlorodiethyl ether: MAK Value Documentation, addendum - Translation of the German version from 2023. | MAK Collect Occup Health Saf | 2026 | https://conductscience.org/library/papers/42657353 | PubMed |
| 42164650 | Tetrahydrofuran: MAK-Begründung, Nachtrag. | MAK Collect Occup Health Saf | 2024 | https://conductscience.org/library/papers/42164650 | PubMed |
| 41973604 | 2-Mercaptobenzothiazole: MAK Value Documentation, addendum - Translation of the German version from 2022. | MAK Collect Occup Health Saf | 2025 | https://conductscience.org/library/papers/41973604 | PubMed |
| 41971572 | Tetrabromobisphenol A: MAK Value Documentation - Translation of the German version from 2023. | MAK Collect Occup Health Saf | 2025 | https://conductscience.org/library/papers/41971572 | PubMed |
| 41586717 | 1,1-Dichlorethen: MAK-Begründung, Nachtrag. | MAK Collect Occup Health Saf | 2025 | https://conductscience.org/library/papers/41586717 | PubMed |
| 41586703 | Trichlorobenzene (all isomers): MAK Value Documentation, addendum - Translation of the German version from 2022. | MAK Collect Occup Health Saf | 2025 | https://conductscience.org/library/papers/41586703 | PubMed |
| 41586701 | Naphthalene: MAK Value Documentation, addendum - Translation of the German version from 2022. | MAK Collect Occup Health Saf | 2025 | https://conductscience.org/library/papers/41586701 | PubMed |
| 41586081 | N,N-Dimethyl-p-toluidine: MAK Value Documentation - Translation of the German version from 2022. | MAK Collect Occup Health Saf | 2025 | https://conductscience.org/library/papers/41586081 | PubMed |
| 41562760 | Cancer and Environmental Xenobiotics: Mechanisms, Controversies, and Innovations. | J Xenobiot | 2025 | https://conductscience.org/library/papers/41562760 | PubMed |
| 38420937 | Potent lung tumor promotion by inhaled MWCNT. | Nanotoxicology | 2024 | https://conductscience.org/library/papers/38420937 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31433998
GET https://conductscience.org/api/papers/v1/31433998/authors